FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Fuminori Sakurai

Research Profile

Chemicals & Drugs

Living Beings

Physiology

Co-author Network

Publications

TOP 3
Hayato Matsui; Fuminori Sakurai; Masashi Tachibana; Yasuhiro Abe; Kazufumi Katayama; Shinnosuke Kurachi; Mitsuhiro Machitani; Hiroyuki Mizuguchi
A targeted adenovirus vector displaying a human fibronectin type III domain-based monobody in a fiber protein.
Kazuo Takayama; Katsuhisa Tashiro; Yasuhito Nagamoto; Fuminori Sakurai; Masashi Tachibana; Miho Kusuda Furue; Takao Hayakawa; Katsuhiro Kanda; Kenji Kawabata; Keisuke Kishimoto; Hiroyuki Mizuguchi
3D spheroid culture of hESC/hiPSC-derived hepatocyte-like cells for drug toxicity testing.
Fuminori Sakurai; Toshiyoshi Fujiwara; Hiroyuki Mizuguchi
[Development of a detection system for circulating tumor cells in peripheral blood using a next generation conditionally-replicating adenovirus].

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Fuminori Sakurai (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Hayato Matsui; Fuminori Sakurai; Masashi Tachibana; Yasuhiro Abe; Kazufumi Katayama; Shinnosuke Kurachi; Mitsuhiro Machitani; Hiroyuki Mizuguchi
A targeted adenovirus vector displaying a human fibronectin type III domain-based monobody in a fiber protein.
Biomaterials 2013;34(16):4191-201.
2013: Kazuo Takayama; Katsuhisa Tashiro; Yasuhito Nagamoto; Fuminori Sakurai; Masashi Tachibana; Miho Kusuda Furue; Takao Hayakawa; Katsuhiro Kanda; Kenji Kawabata; Keisuke Kishimoto; Hiroyuki Mizuguchi
3D spheroid culture of hESC/hiPSC-derived hepatocyte-like cells for drug toxicity testing.
Biomaterials 2013;34(7):1781-9.
2013: Fuminori Sakurai; Toshiyoshi Fujiwara; Hiroyuki Mizuguchi
[Development of a detection system for circulating tumor cells in peripheral blood using a next generation conditionally-replicating adenovirus].
Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan 2013;133(3):291-6.
2013: Fuminori Sakurai; Masuo Kondoh
[New approaches to drug discovery research and medical treatment using viruses--viruses are valuable biomaterials].
Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan 2013;133(3):289.
2012: Masaki Shoji; Masashi Tachibana; Kyoko Tomita; Kazufumi Katayama; Kenji Kawabata; Fuminori Sakurai; Hiroyuki Mizuguchi
Intramuscular DNA immunization with in vivo electroporation induces antigen-specific cellular and humoral immune responses in both systemic and gut-mucosal compartments.
Vaccine 2012;30(50):7278-85.
2012: Kazuo Takayama; Katsuhisa Tashiro; Hitoshi Watanabe; Yasuhito Nagamoto; Fuminori Sakurai; Michiko Sugawara; Miho Kusuda Furue; Takao Hayakawa; Maiko Higuchi; Mitsuru Inamura; Kenji Kawabata; Kiyomi Kikuchi; Hiroyuki Mizuguchi
Generation of metabolically functioning hepatocytes from human pluripotent stem cells by FOXA2 and HNF1α transduction.
Journal of hepatology 2012;57(3):628-36.
2012: Masaki Shoji; Masashi Tachibana; Kyoko Tomita; Sayaka Tsuzuki; Shizuo Akira; Ken J Ishii; Kazufumi Katayama; Kenji Kawabata; Fuminori Sakurai; Hiroyuki Mizuguchi
Type-I IFN signaling is required for the induction of antigen-specific CD8(+) T cell responses by adenovirus vector vaccine in the gut-mucosa.
Biochemical and biophysical research communications 2012;425(1):89-93.
2012: Yasuhito Nagamoto; Kazuo Ohashi; Fuminori Sakurai; Masashi Tachibana; Kazuo Takayama; Katsuhisa Tashiro; Miho Kusuda Furue; Takao Hayakawa; Kenji Kawabata; Hiroyuki Mizuguchi
The promotion of hepatic maturation of human pluripotent stem cells in 3D co-culture using type I collagen and Swiss 3T3 cell sheets.
Biomaterials 2012;33(18):4526-34.
2012: Hayato Matsui; Kazufumi Katayama; Shinsaku Nakagawa; Sayuri Okamoto; Fuminori Sakurai; Masashi Tachibana; Kohdai Takahira; Tomoko Yamaguchi; Hiroyuki Mizuguchi
A hexon-specific PEGylated adenovirus vector utilizing blood coagulation factor X.
Biomaterials 2012;33(14):3743-55.
2012: Fuminori Sakurai; Kiyohito Yagi; Takeshi Yoshida; Sayuri Okamoto; Kaori Ono; Naoya Sakamoto; Norihisa Furukawa; Maiko Higuchi; Kazufumi Katayama; Masuo Kondoh; Hiroyuki Mizuguchi
Suppression of hepatitis C virus replicon by adenovirus vector-mediated expression of tough decoy RNA against miR-122a.
Virus research 2012;165(2):214-8.
2012: Kyoko Tomita; Fuminori Sakurai; Masashi Tachibana; Hiroyuki Mizuguchi
Correlation between adenovirus-neutralizing antibody titer and adenovirus vector-mediated transduction efficiency following intratumoral injection.
Anticancer research 2012;32(4):1145-52.
2012: Kahori Shimizu; Masashi Tachibana; Fuminori Sakurai; Hiroyuki Mizuguchi
[Development of a novel adenovirus vector exhibiting microRNA-mediated suppression of the leaky expression of adenovirus genes].
Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan 2012;132(12):1407-12.
2011: Mitsuhiro Machitani; Hayato Matsui; Hiroyuki Miyoshi; Kazufumi Katayama; Kenji Kawabata; Fuminori Sakurai; Takayuki Suzuki; Tomoko Yamaguchi; Hiroyuki Mizuguchi
Development of an adenovirus vector lacking the expression of virus-associated RNAs.
Journal of controlled release : official journal of the Controlled Release Society 2011;154(3):285-9.
2011: Yukari Motegi; Fuminori Sakurai; Masahide Takahashi; Tomoko Yamaguchi; Kazufumi Katayama; Takuya Kato; Kenji Kawabata; Hayato Matsui; Hiroyuki Mizuguchi
An effective gene-knockdown using multiple shRNA-expressing adenovirus vectors.
Journal of controlled release : official journal of the Controlled Release Society 2011;153(2):149-53.
2011: Takayuki Suzuki; Tomomi Sasaki; Koyori Yano; Fuminori Sakurai; Kenji Kawabata; Masuo Kondoh; Takao Hayakawa; Kiyohito Yagi; Hiroyuki Mizuguchi
Development of a recombinant adenovirus vector production system free of replication-competent adenovirus by utilizing a packaging size limit of the viral genome.
Virus research 2011;158(1-2):154-60.
2011: Kazufumi Katayama; Rie Furuki; Hideaki Yokoyama; Makoto Kaneko; Masashi Tachibana; Ichiro Yoshida; Hisamitsu Nagase; Keiichi Tanaka; Fuminori Sakurai; Hiroyuki Mizuguchi; Shinsaku Nakagawa; Tsuyoshi Nakanishi
Enhanced in vivo gene transfer into the placenta using RGD fiber-mutant adenovirus vector.
Biomaterials 2011;32(17):4185-93.
2011: Kumiko Sugio; Katsuhisa Tashiro; Fuminori Sakurai; Toshiyoshi Fujiwara; Takao Hayakawa; Masahiro Iwaki; Kazufumi Katayama; Kenji Kawabata; Atsushi Kawase; Hayato Matsui; Hiroyuki Mizuguchi
Enhanced safety profiles of the telomerase-specific replication-competent adenovirus by incorporation of normal cell-specific microRNA-targeted sequences.
Clinical cancer research : an official journal of the American Association for Cancer Research 2011;17(9):2807-18.
2011: Emi Suzuki-Kouyama; Kazufumi Katayama; Fuminori Sakurai; Tomoko Yamaguchi; Shinnosuke Kurachi; Kenji Kawabata; Shinsaku Nakagawa; Hiroyuki Mizuguchi
Hexon-specific PEGylated adenovirus vectors utilizing avidin-biotin interaction.
Biomaterials 2011;32(6):1724-30.
2011: Mitsuru Inamura; Kenji Kawabata; Kazuo Takayama; Katsuhisa Tashiro; Fuminori Sakurai; Kazufumi Katayama; Masashi Toyoda; Hidenori Akutsu; Yoshitaka Miyagawa; Hajime Okita; Nobutaka Kiyokawa; Akihiro Umezawa; Takao Hayakawa; Miho Kusuda Furue; Hiroyuki Mizuguchi
Efficient generation of hepatoblasts from human ES cells and iPS cells by transient overexpression of homeobox gene HEX.
Molecular therapy : the journal of the American Society of Gene Therapy 2011;19(2):400-7.
2011: Kazuo Takayama; Katsuhisa Tashiro; Fuminori Sakurai; Miho Kusuda Furue; Takao Hayakawa; Mitsuru Inamura; Kazufumi Katayama; Kenji Kawabata; Hiroyuki Mizuguchi
Efficient and directive generation of two distinct endoderm lineages from human ESCs and iPSCs by differentiation stage-specific SOX17 transduction.
PloS one 2011;6(7):e21780.
2011: Fuminori Sakurai; Kazufumi Katayama; Hiroyuki Mizuguchi
MicroRNA-regulated transgene expression systems for gene therapy and virotherapy.
Frontiers in bioscience : a journal and virtual library 2011;16():2389-401.
2011: Hayato Matsui; Fuminori Sakurai; Kazufumi Katayama; Shinnosuke Kurachi; Katsuhisa Tashiro; Kumiko Sugio; Kenji Kawabata; Hiroyuki Mizuguchi
Enhanced transduction efficiency of fiber-substituted adenovirus vectors by the incorporation of RGD peptides in two distinct regions of the adenovirus serotype 35 fiber knob.
Virus research 2011;155(1):48-54.
2010: Fuminori Sakurai; Kazuko Nakashima; Tomoko Yamaguchi; Takako Ichinose; Kenji Kawabata; Takao Hayakawa; Hiroyuki Mizuguchi
Adenovirus serotype 35 vector-induced innate immune responses in dendritic cells derived from wild-type and human CD46-transgenic mice: Comparison with a fiber-substituted Ad vector containing fiber proteins of Ad serotype 35.
Journal of controlled release : official journal of the Controlled Release Society 2010;148(2):212-8.
2010: Fuminori Sakurai; Hiroyuki Mizuguchi
[Development of recombinant adenovirus carrying microRNA-regulated gene expression system].
Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan 2010;130(11):1497-504.
2010: Fuminori Sakurai; Makiya Nishikawa
[Development of cellular and gene therapy products for bioacitve protein-based therapy].
Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan 2010;130(11):1487-8.
2010: Tomoko Yamaguchi; Kenji Kawabata; Emi Kouyama; Ken J Ishii; Kazufumi Katayama; Takayuki Suzuki; Shinnosuke Kurachi; Fuminori Sakurai; Shizuo Akira; Hiroyuki Mizuguchi
Induction of type I interferon by adenovirus-encoded small RNAs.
Proceedings of the National Academy of Sciences of the United States of America 2010;107(40):17286-91.
2010: Masahiro Ushitora; Fuminori Sakurai; Tomoko Yamaguchi; Shin-ichiro Nakamura; Masuo Kondoh; Kiyohito Yagi; Kenji Kawabata; Hiroyuki Mizuguchi
Prevention of hepatic ischemia-reperfusion injury by pre-administration of catalase-expressing adenovirus vectors.
Journal of controlled release : official journal of the Controlled Release Society 2010;142(3):431-7.
2009: Katsuhisa Tashiro; Mitsuru Inamura; Kenji Kawabata; Fuminori Sakurai; Koichi Yamanishi; Takao Hayakawa; Hiroyuki Mizuguchi
Efficient adipocyte and osteoblast differentiation from mouse induced pluripotent stem cells by adenoviral transduction.
Stem cells (Dayton, Ohio) 2009;27(8):1802-11.
2009: H Matsui; Fuminori Sakurai; Shinnosuke Kurachi; Katsuhisa Tashiro; K Sugio; Kenji Kawabata; Koichi Yamanishi; Hiroyuki Mizuguchi
Development of fiber-substituted adenovirus vectors containing foreign peptides in the adenovirus serotype 35 fiber knob.
Gene therapy 2009;16(8):1050-7.
2009: Fuminori Sakurai; S-i Nakamura; K Akitomo; H Shibata; K Terao; Kenji Kawabata; Takao Hayakawa; Hiroyuki Mizuguchi
Adenovirus serotype 35 vector-mediated transduction following direct administration into organs of nonhuman primates.
Gene therapy 2009;16(2):297-302.
2009: Katsuhisa Tashiro; Asami Kondo; Kenji Kawabata; Haruna Sakurai; Fuminori Sakurai; Koichi Yamanishi; Takao Hayakawa; Hiroyuki Mizuguchi
Efficient osteoblast differentiation from mouse bone marrow stromal cells with polylysin-modified adenovirus vectors.
Biochemical and biophysical research communications 2009;379(1):127-32.
2008: Fuminori Sakurai
[Development of a replication-incompetent adenovirus vector derived from subgroup B adenovirus serotype 35].
Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan 2008;128(12):1751-61.
2008: Fuminori Sakurai
Development and evaluation of a novel gene delivery vehicle composed of adenovirus serotype 35.
Biological & pharmaceutical bulletin 2008;31(10):1819-25.
2008: Takayuki Suzuki; Fuminori Sakurai; Shin-ichiro Nakamura; Emi Kouyama; Kenji Kawabata; Masuo Kondoh; Kiyohito Yagi; Hiroyuki Mizuguchi
miR-122a-regulated expression of a suicide gene prevents hepatotoxicity without altering antitumor effects in suicide gene therapy.
Molecular therapy : the journal of the American Society of Gene Therapy 2008;16(10):1719-26.
2008: Kazuko Nakashima; Fuminori Sakurai; Kenji Kawabata; Hiroyuki Mizuguchi
Efficient gene delivery in human and rodent mast cells using adenovirus vectors.
Journal of controlled release : official journal of the Controlled Release Society 2008;129(3):215-22.
2008: Naoko Kanagawa; Ryosuke Koretomo; Sayaka Murakami; Fuminori Sakurai; Hiroyuki Mizuguchi; Shinsaku Nakagawa; Takuya Fujita; Akira Yamamoto; Naoki Okada
Factors involved in the maturation of murine dendritic cells transduced with adenoviral vector variants.
Virology 2008;374(2):411-20.
2008: Katsuhisa Tashiro; Kenji Kawabata; Haruna Sakurai; Shinnosuke Kurachi; Fuminori Sakurai; Koichi Yamanishi; Hiroyuki Mizuguchi
Efficient adenovirus vector-mediated PPAR gamma gene transfer into mouse embryoid bodies promotes adipocyte differentiation.
The journal of gene medicine 2008;10(5):498-507.
2008: Haruna Sakurai; Kenji Kawabata; Fuminori Sakurai; Shinsaku Nakagawa; Hiroyuki Mizuguchi
Innate immune response induced by gene delivery vectors.
International journal of pharmaceutics 2008;354(1-2):9-15.
2008: Shinnosuke Kurachi; Naoya Koizumi; Katsuhisa Tashiro; Haruna Sakurai; Fuminori Sakurai; Kenji Kawabata; Shinsaku Nakagawa; Hiroyuki Mizuguchi
Modification of pIX or hexon based on fiberless Ad vectors is not effective for targeted Ad vectors.
Journal of controlled release : official journal of the Controlled Release Society 2008;127(1):88-95.
2008: Fuminori Sakurai; Shin-ichiro Nakamura; Kimiyo Akitomo; Hiroaki Shibata; Keiji Terao; Kenji Kawabata; Takao Hayakawa; Hiroyuki Mizuguchi
Transduction properties of adenovirus serotype 35 vectors after intravenous administration into nonhuman primates.
Molecular therapy : the journal of the American Society of Gene Therapy 2008;16(4):726-33.
2008: Haruna Sakurai; Katsuhisa Tashiro; Kenji Kawabata; Tomoko Yamaguchi; Fuminori Sakurai; Shinsaku Nakagawa; Hiroyuki Mizuguchi
Adenoviral expression of suppressor of cytokine signaling-1 reduces adenovirus vector-induced innate immune responses.
Journal of immunology (Baltimore, Md. : 1950) 2008;180(7):4931-8.
2007: S Murakami; Fuminori Sakurai; Kenji Kawabata; Naoki Okada; T Fujita; A Yamamoto; Takao Hayakawa; Hiroyuki Mizuguchi
Interaction of penton base Arg-Gly-Asp motifs with integrins is crucial for adenovirus serotype 35 vector transduction in human hematopoietic cells.
Gene therapy 2007;14(21):1525-33.
2007: Jian-Qing Gao; Yusuke Eto; Yasuo Yoshioka; Fumiko Sekiguchi; Shinnosuke Kurachi; Tomohiro Morishige; Xinglei Yao; Hikaru Watanabe; Ratima Asavatanabodee; Fuminori Sakurai; Hiroyuki Mizuguchi; Yuka Okada; Yohei Mukai; Yasuo Tsutsumi; Tadanori Mayumi; Naoki Okada; Shinsaku Nakagawa
Effective tumor targeted gene transfer using PEGylated adenovirus vector via systemic administration.
Journal of controlled release : official journal of the Controlled Release Society 2007;122(1):102-10.
2007: Fuminori Sakurai; Kenji Kawabata; Hiroyuki Mizuguchi
Adenovirus vectors composed of subgroup B adenoviruses.
Current gene therapy 2007;7(4):229-38.
2007: Tomoko Yamaguchi; Kenji Kawabata; Naoya Koizumi; Fuminori Sakurai; Kazuko Nakashima; Haruna Sakurai; Tomomi Sasaki; Naoki Okada; Koichi Yamanishi; Hiroyuki Mizuguchi
Role of MyD88 and TLR9 in the innate immune response elicited by serotype 5 adenoviral vectors.
Human gene therapy 2007;18(8):753-62.
2007: Kenji Kawabata; Katsuhisa Tashiro; Fuminori Sakurai; Naoki Osada; Jun Kusuda; Takao Hayakawa; Koichi Yamanishi; Hiroyuki Mizuguchi
Positive and negative regulation of adenovirus infection by CAR-like soluble protein, CLSP.
Gene therapy 2007;14(16):1199-207.
2007: Shinnosuke Kurachi; Katsuhisa Tashiro; Fuminori Sakurai; Haruna Sakurai; Kenji Kawabata; K Yayama; H Okamoto; Shinsaku Nakagawa; Hiroyuki Mizuguchi
Fiber-modified adenovirus vectors containing the TAT peptide derived from HIV-1 in the fiber knob have efficient gene transfer activity.
Gene therapy 2007;14(15):1160-5.
2007: Fuminori Sakurai; K Akitomo; Kenji Kawabata; Takao Hayakawa; Hiroyuki Mizuguchi
Downregulation of human CD46 by adenovirus serotype 35 vectors.
Gene therapy 2007;14(11):912-9.
2007: Eri Mukai; Shimpei Fujimoto; Fuminori Sakurai; Kenji Kawabata; Manabu Yamashita; Nobuya Inagaki; Hiroyuki Mizuguchi
Efficient gene transfer into murine pancreatic islets using adenovirus vectors.
Journal of controlled release : official journal of the Controlled Release Society 2007;119(1):136-41.
2007: Haruna Sakurai; Fuminori Sakurai; Kenji Kawabata; Tomomi Sasaki; Naoya Koizumi; Haiying Huang; Katsuhisa Tashiro; Shinnosuke Kurachi; Shinsaku Nakagawa; Hiroyuki Mizuguchi
Comparison of gene expression efficiency and innate immune response induced by Ad vector and lipoplex.
Journal of controlled release : official journal of the Controlled Release Society 2007;117(3):430-7.
2007: Naoya Koizumi; Tomoko Yamaguchi; Kenji Kawabata; Fuminori Sakurai; Tomomi Sasaki; Yoshiteru Watanabe; Takao Hayakawa; Hiroyuki Mizuguchi
Fiber-modified adenovirus vectors decrease liver toxicity through reduced IL-6 production.
Journal of immunology (Baltimore, Md. : 1950) 2007;178(3):1767-73.
2007: Shinnosuke Kurachi; Naoya Koizumi; Fuminori Sakurai; Kenji Kawabata; Haruna Sakurai; Shinsaku Nakagawa; Takao Hayakawa; Hiroyuki Mizuguchi
Characterization of capsid-modified adenovirus vectors containing heterologous peptides in the fiber knob, protein IX, or hexon.
Gene therapy 2007;14(3):266-74.
2006: Fuminori Sakurai; Kenji Kawabata; Hiroyuki Mizuguchi
[Characterization of adenovirus serotype 35 vectors using genetically modified animals and non-human primates].
Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan 2006;126(11):1013-9.
2006: Fuminori Sakurai; Sayaka Murakami; Kenji Kawabata; Naoki Okada; Akira Yamamoto; Tsukasa Seya; Takao Hayakawa; Hiroyuki Mizuguchi
The short consensus repeats 1 and 2, not the cytoplasmic domain, of human CD46 are crucial for infection of subgroup B adenovirus serotype 35.
Journal of controlled release : official journal of the Controlled Release Society 2006;113(3):271-8.
2006: Fuminori Sakurai; Kenji Kawabata; Naoya Koizumi; N Inoue; M Okabe; Teruhide Yamaguchi; Takao Hayakawa; Hiroyuki Mizuguchi
Adenovirus serotype 35 vector-mediated transduction into human CD46-transgenic mice.
Gene therapy 2006;13(14):1118-26.
2006: Kenji Kawabata; Fuminori Sakurai; Naoya Koizumi; Takao Hayakawa; Hiroyuki Mizuguchi
Adenovirus vector-mediated gene transfer into stem cells.
Molecular pharmaceutics 2006;3(2):95-103.
2005: Hiroyuki Mizuguchi; Zhi-Li Xu; Fuminori Sakurai; Kenji Kawabata; Teruhide Yamaguchi; Takao Hayakawa
Efficient regulation of gene expression using self-contained fiber-modified adenovirus vectors containing the tet-off system.
Journal of controlled release : official journal of the Controlled Release Society 2005;110(1):202-11.
2005: Fuminori Sakurai; Kenji Kawabata; Teruhide Yamaguchi; Takao Hayakawa; Hiroyuki Mizuguchi
Optimization of adenovirus serotype 35 vectors for efficient transduction in human hematopoietic progenitors: comparison of promoter activities.
Gene therapy 2005;12(19):1424-33.
2005: Kenji Kawabata; Fuminori Sakurai; Teruhide Yamaguchi; Takao Hayakawa; Hiroyuki Mizuguchi
Efficient gene transfer into mouse embryonic stem cells with adenovirus vectors.
Molecular therapy : the journal of the American Society of Gene Therapy 2005;12(3):547-54.
2005: Hiroyuki Mizuguchi; Tomomi Sasaki; Kenji Kawabata; Fuminori Sakurai; Takao Hayakawa
Fiber-modified adenovirus vectors mediate efficient gene transfer into undifferentiated and adipogenic-differentiated human mesenchymal stem cells.
Biochemical and biophysical research communications 2005;332(4):1101-6.
2005: Zhi-Li Xu; Hiroyuki Mizuguchi; Fuminori Sakurai; Naoya Koizumi; Tetsuji Hosono; Kenji Kawabata; Yoshiteru Watanabe; Teruhide Yamaguchi; Takao Hayakawa
Approaches to improving the kinetics of adenovirus-delivered genes and gene products.
Advanced drug delivery reviews 2005;57(5):781-802.
2004: Tetsuji Hosono; Hiroyuki Mizuguchi; Kazufumi Katayama; Zhi-Li Xu; Fuminori Sakurai; Akiko Ishii-Watabe; Kenji Kawabata; Teruhide Yamaguchi; Shinsaku Nakagawa; Tadanori Mayumi; Takao Hayakawa
Adenovirus vector-mediated doxycycline-inducible RNA interference.
Human gene therapy 2004;15(8):813-9.
2003: Naoya Koizumi; Hiroyuki Mizuguchi; Fuminori Sakurai; Teruhide Yamaguchi; Yoshiteru Watanabe; Takao Hayakawa
Reduction of natural adenovirus tropism to mouse liver by fiber-shaft exchange in combination with both CAR- and alphav integrin-binding ablation.
Journal of virology 2003;77(24):13062-72.
2003: Fuminori Sakurai; Hiroyuki Mizuguchi; Teruhide Yamaguchi; Takao Hayakawa
Characterization of in vitro and in vivo gene transfer properties of adenovirus serotype 35 vector.
Molecular therapy : the journal of the American Society of Gene Therapy 2003;8(5):813-21.
2003: Hiroyuki Mizuguchi; Zhi-Li Xu; Fuminori Sakurai; Tadanori Mayumi; Takao Hayakawa
Tight positive regulation of transgene expression by a single adenovirus vector containing the rtTA and tTS expression cassettes in separate genome regions.
Human gene therapy 2003;14(13):1265-77.
2003: Fuminori Sakurai; Hiroyuki Mizuguchi; Takao Hayakawa
Efficient gene transfer into human CD34+ cells by an adenovirus type 35 vector.
Gene therapy 2003;10(12):1041-8.